New study tests better way to rebuild jawbone for dental implants

NCT ID NCT07613047

First seen Jun 06, 2026

Summary

This study compares two barrier materials used in guided bone regeneration to rebuild the jawbone in areas where teeth are missing. Seventy adults needing horizontal ridge augmentation will be randomly assigned to receive either acellular dermal matrix or a resorbable collagen membrane. The goal is to see which material better restores bone width and improves soft tissue outcomes for future dental implants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE GRAFTING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

acellular dermal matrix (AlloDerm) and resorbable cross-linked collagen membrane

What this could lead to

If successful, this could show that acellular dermal matrix is a better option for rebuilding jawbone width, potentially improving dental implant success.

What could go wrong

This is an early-stage study with only 70 participants, so results may not apply to everyone. The procedure involves surgery with risks like pain, swelling, or infection.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.